Deciphera Pharmaceuticals at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Deciphera Pharmaceuticals brings 1 presentation to ASH 2026 in New Orleans, and exhibits at Booth 3731. Its program centres on primary central nervous system lymphoma. It hosts a session on evolving treatment approaches and supports a live tumor board.
| Organization | ASH 2026 Attendance |
|---|---|
Deciphera Pharmaceuticals Waltham, MA | |
Oncology company owned by Ono Pharmaceutical, developing and marketing kinase-inhibitor cancer medicines. | Booth Exhibiting at Booth 3731 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm Symposium Fri Dec 11 3:00pm–6:00pm Live Tumor Board: Advancing Clinical Competence in Primary CNS Lymphoma — Navigating Molecular Pathways and Emerging Therapies Treating primary central nervous system lymphoma, from methotrexate-based induction and consolidation choices to new drugs aimed at its signaling mutations. Talk Mon Dec 14 8:00am–9:00am |
Find decision makers at Deciphera Pharmaceuticals
Tell us what you sell and we’ll find the people at Deciphera Pharmaceuticals most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction